facility expansion

The Shenzhen-based company offers personal genomics services in China that are similar to those provided by 23andMe, Ancestry, and Helix in the US.

Centogene opened a Boston office in December and plans to open a lab there in a few months as it awaits an FDA decision on its clinical tool.

The company will use some of the funds to set up a new research laboratory within the US to better support collaborations with pharma and biotech.

NEW YORK (GenomeWeb) – Illumina will build a new 150,000-square-foot facility in San Diego to house manufacturing and logistics, the company and the city said on Tuesday.

NEW YORK (GenomeWeb News) – Boston University has proposed building a new research center that will house interdisciplinary life sciences research projects involving systems and synthetic biology and neuroscience.

NEW YORK (GenomeWeb News) – Life Technologies today announced it will invest $18 million to expand its facility in Pleasanton, Calif., where the company will implement current good manufacturing practice capabilities for its genetic analysis products.

NEW YORK (GenomeWeb News) – The Jackson Laboratory has bought a building on a 17-acre property in Ellsworth, Me., located a few miles from its main campus in Bar Harbor for an undisclosed sum.

NEW YORK (GenomeWeb News) – Jackson Laboratory said yesterday that it has begun a $27 million expansion of its Jax-West facility in Sacramento.

NEW YORK (GenomeWeb News) – Exact Sciences will expand into 10,000-square-feet of additional space at University Research Park at the University of Wisconsin, Madison, while Epicentre will move its Madison operations into a 27,000-square-foot space at the park, URP announced on Wednesday.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.